Using risk and odds ratios to assess effect size for meta-analysis outcome measures by Alavi, Mousa et al.
1 
Submit to: Journal of Advanced Nursing 
Type: Editorial 
Title: Using risk and odds ratios to assess effect size for meta-analysis outcome measures 
Authors: Mousa ALAVI, Glenn E HUNT, Denis C VISENTIN, Roger WATSON, 
Deependra K THAPA, Michelle CLEARY 
Mousa ALAVI, PhD, Department of Psychiatric Nursing, School of Nursing and Midwifery, 
Isfahan University of Medical Sciences, Hezarjarib Avenue, Isfahan, Iran.  
***corresponding author, Email: m_alavi@nm.mui.ac.ir ORCID: https://orcid.org/0000-0003-
4847-2915  
Glenn E. HUNT, PhD, Discipline of Psychiatry, Concord Clinical School, The University of 
Sydney, NSW, Australia. Email: glenn.hunt@sydney.edu.au ORCID: http://orchid.org/0000-
0002-8088-9406 
Denis C. VISENTIN, PhD, College of Health and Medicine, University of Tasmania, Sydney, 
NSW, Australia. Email: denis.visentin@utas.edu.au ORCID: https://orcid.org/0000-0001-
9961-4384  
Roger WATSON, RN, PhD, FAAN, Faculty of Health Sciences, University of Hull, Hull, UK. 
Email: r.watson@hull.ac.uk ORCID: https://orcid.org/0000-0001-8040-7625 
Deependra K. THAPA, MPH, MSc, College of Health and Medicine, University of Tasmania, 
Sydney, NSW, Australia.  Email: deependrakaji.thapa@utas.edu.au ORCID: 
https://orcid.org/0000-0002-5689-0837 
Michelle CLEARY, RN, PhD, College of Health and Medicine, University of Tasmania, 
Sydney, NSW, Australia. Email: michelle.cleary@utas.edu.au ORCID: http://orcid.org/0000-
0002-1453-4850 
Conflict of Interest statement: Nil 
Author contributions: All authors have agreed on the final version and meet at least one of 
the following criteria recommended by the ICMJE 
(http://www.icmje.org/recommendations/)]: 
• Substantial contributions to conception and design, acquisition of data or analysis and
interpretation of data; drafting the article or revising it critically for important
intellectual content.
This is the accepted version of the following article: Alavi, M., Hunt, G.E., Visentin, D.C., Watson, R., Thapa, D.K. and 
Cleary, M. (2020), Using risk and odds ratios to assess effect size for meta‐analysis outcome measures. J Adv Nurs., which has 
been published in final form at  https://doi.org/10.1111/jan.14528.  This article may be used for non-commercial purposes in 
accordance with Wiley Terms and Conditions for self-archiving.
2 
 
Using risk and odds ratios to assess effect size for meta-analysis outcome measures 
1. INTRODUCTION 
Best practice is built on the principle of aggregating all available evidence on a topic to make 
a clinical decision on the most appropriate intervention for the situation at hand. Systematic 
reviews and meta-analyses are powerful tools that summarize the evidence for current best 
practice guidelines for the available interventions for a particular problem (Moher, Liberati, 
Tetzlaff, Altman, & PRISMA Group, 2009). Meta-analysis combines the results of multiple 
studies to produce an aggregated and more precise estimates of the benefits of the interventions. 
Meta-analysis of high-quality randomized trials are considered the highest level of evidence to 
inform practice. 
When reading the healthcare literature, several measures of the effect of an intervention on an 
outcome are available to judge whether the evidence presented can be applied to clinical 
practice. It is important to be able to understand, correctly interpret and honestly communicate 
these reported measures (Thapa, Visentin, Hunt, Watson, & Cleary, 2020). However, it is not 
uncommon for clinicians and researchers to be confused about the differences between the 
various effect measures available (Tufanaru, Munn, Stephenson, & Aromataris, 2015). These 
will be outlined further in this editorial, with a focus on the odds ratio and risk ratio.  
2. MEASURES OF EFFECT SIZE IN CLINICAL STUDIES  
The three most common designs used to assess the effectiveness of a given intervention are 
case-control studies, cohort studies and randomized controlled trials (RCTs; Knol, Algra, & 
Groenwold, 2012). These studies estimate the measures of association, and hence the 
effectiveness of the intervention using various measures of effect (Schäfer & Schwarz, 2019). 
Quantitative indicators of the magnitude and direction of the effect of any intervention on a 
respective outcome is called the effect size (Tufanaru et al., 2015).  
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Key statistics applied in a meta-analysis allow researchers to draw conclusions through 
comparing standardized effect sizes across several studies (Feingold, 2017, Lakens, 2013). By 
undertaking a meta-analysis, we aim to arrive at a weighted combination of the effect sizes 
reported by several studies as a pooled estimation of the outcome of interest. In addition, meta-
analysis often consists of the test for effect (i.e. risk factor or treatment effect), which can be 
represented either as a p-value and/or a confidence interval expressing the range of likely effect 
sizes (Visentin & Hunt, 2017). Moreover, it consists of a test for heterogeneity, whether the 
effect varies across the studies included.  
Identification of the outcomes reported in the individual studies to be extracted for the meta-
analysis is a crucial step in meta-analysis. The choice of effect measure reported depends on 
the type of outcome variable used in a particular study, which can be dichotomous, continuous 
or ordinal based on the outcome measures used. For dichotomous outcomes, risk ratio or 
relative risk (RR), odds ratio (OR) and risk difference (RD) can be used to assess differences 
between two groups. A mean difference or a standardized mean difference can be used to assess 
between-group comparisons of continuous outcomes (Higgins, Li, & Deeks, 2019). The 
interventions may have no effect, decrease the risk of an adverse outcome, or increase the 
chance of a desired outcome. In situations where the interventions are shown to reduce the 
occurrence of adverse outcomes, the OR and RR will be less than 1, and the RD negative. 
Where the intervention increases the occurrence of a desired outcome, the OR and RR will be 
greater than 1, with a positive RD (Deeks, Higgins, & Altman, 2008). Alternatively, when the 
intervention is ineffective the OR and RR will be near one, and the RD close to zero.  
Two examples will be used to illustrate similarities and differences between RR and OR in this 
editorial. The first describes an RCT that assesses the impact of implementing a psychological 
support program on the status of depression as a dichotomous outcome event among 200 nurses 
caring for cancer patients. The second example describes a case-control study to assess 
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Substance Use Disorder among 620 subjects, of which 200 patients (cases) have a Generalized 
Anxiety Disorder and 420 people without Generalized Anxiety Disorder (controls) are 
recruited to assess Substance Use Disorder differences between the groups. The studies are 
summarized in Table 1. 
3. DIFFERENCES BETWEEN RISK, ODDS, OR AND RR  
The terms ‘risk’ and ‘odds’ are often used interchangeably. However, they have specific 
meanings in statistics and are calculated in different ways (Tufanaru et al., 2015). It is important 
to understand the differences between RR and OR when interpreting the results of a meta-
analysis as there are subtle differences that need to be considered when interpreting the effect 
sizes (Deeks et al., 2008). 
The risk describes the probability of an event, usually an adverse health outcome. It is a decimal 
number between 0 and 1, sometimes converted to a percentage or presented as number of events 
per 1000 people. For example, in the RCT example of 100 nurses who did not receive 
psychological support, 70 had depression – a risk of 0.7, 70 per 100 or 700 per 1000 nurses. 
The RR is the ratio of risk of the outcome event in one group (e.g., intervention group or treated 
subjects) to the risk of the outcome event in another group (e.g., control group or untreated 
subjects. The risks in the treatment and control groups in the RCT example are 0.35 and 0.7 
respectively, giving an RR of (35/100)/(70/100) = 0.5 (Table 1). This means that the risk of 
being depressed in the treatment group is half the risk in the group that did not receive the 
treatment, indicating better mental health for those receiving the psychological support 
program.  
The RR provides a relative measure of association. However, we also have an absolute measure 
of association, the RD, commonly expressed as a percentage, calculated from the difference of 
the risks of the outcome event occurring between the two groups (i.e. the risk in one group 
5 
 
minus the risk for another group). For the study RCT example, this is 35/100 – 70/100 = –0.35 
= –35% (Table 1b). The RD helps to put the RR into context, as it takes into account the 
incidence of the outcome. For example, in our illustrated RCT, the RR of 0.5 indicates reducing 
the risk of depression from 70% to 35% following participation in the program that corresponds 
to RD of 35%. The same RR statistics of 0.5 could also indicate reducing the risk of depression 
from 0.7% in the control group to 0.35% in the intervention group, which corresponds to RD 
of 0.35% which is much less (i.e. one hundredth) than former RD of 35%. Reporting the 
absolute RD effect size along with the RR may assist to avoid misinterpretation (Tufanaru et 
al., 2015). 
Odds refer to the ratio of the probability of an event occurring to the probability of it not 
occurring within a group. Odds can also be defined as the risk (or probability) of an event 
occurring over the risk of the event being absent (Scott, 2008). Odds and risks can sometimes 
be computed through the following formulae: risk = odds/(1+odds), odds = risk/(1-risk) (Deeks 
et al., 2008) but these relationships depend on the study design and other factors (see below). 
Odds are also expressed as log-odds in some studies. 
The interpretation of odds is more difficult than that of risk as researchers commonly think in 
terms of probability (risk) rather than odds even in studies that report OR (O'Connor, 2013). 
The confusion between risk and odds can lead to an incorrect interpretation of the OR as a 
multiplier for risk of the outcome (Martinez et al., 2017). One way to ensure the correct 
interpretation is to convert the odds to risks. When the outcome event is rare (i.e. less than 
10%), the difference between the odds and risk is small, but when the outcome events are 
higher (e.g., clinical trials), the difference between the odds and risks would be large (Deeks et 
al., 2008). Since many clinical conditions have low incidence, the rare disease assumption 




The OR is preferred and the most popular measure of effect used in meta-analysis of 
dichotomous data (Bakbergenuly, Hoaglin, & Kulinskaya, 2019; Tufanaru et al., 2015). One 
reason for its popularity is that it is the main output of the logistic regression, the statistical 
method widely used in epidemiological studies (Martinez et al., 2017). Another reason is that 
OR can also be used in cross-sectional analytical studies, in addition to case-control studies. 
RR however requires longitudinal studies (cohort or RCT) which assess the incidence of the 
outcome in each group. In the absence of an assessment of incidence, the risk cannot be 
assessed. In cross-sectional and case-cohort studies only odds can be assessed, not risk. The 
OR is the ratio of odds in one group (i.e. the cases in a case control study or intervention group 
participants of an RCT) divided by the odds of the event in another group (i.e. the controls). In 
our case-control study example, the OR is (105/95)/(180/240) = 1.47 (Table 1b).  
In case-control studies the OR is often a good approximation of RR since the outcome event is 
usually rare (i.e. less than 10%; Zlowodzki et al., 2007). The OR could also be calculated in 
RCTs or cohort studies (Knol et al., 2012); however, it can overestimate the magnitude of the 
effect or response in RCTs or cohort studies when the frequency of outcome event is 
large (Ospina, Nydam, & DiCiccio, 2012). When the outcome event rate increases or as the 
treatment effect becomes large, the OR will progressively diverge from the RR (Scott, 2008).  
In our RCT illustration, the OR is (35/65)/(70/30) = 0.23 compared with the RR of 0.5 (Table 
1a). As can be seen, the difference between the two is substantial because in our example the 
incidence of outcome event was high (54%). If the OR is incorrectly interpreted as a RR, it 
may lead to obtaining an overestimate of the risk, especially when the outcome is frequent.  
It is preferable to avoid reporting odds ratios in RCTs and cohort studies to avoid such 
misinterpretations. If ORs are reported in these types of studies, the research team should be 
cautious about misinterpretation of it as a RR; particularly where the outcome is frequent or 
when the OR is not close to 1. For both OR and RR a value of 1 means the same estimated 
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effects for both interventions (i.e. intervention and control). In studies without any outcome 
event in the control group, neither OR not RR can be calculated and in studies where all subjects 
receiving the intervention experience the outcome event, the OR cannot be calculated (Knol et 
al., 2012). 
5. SUMMARY AND CONCLUSION 
Although both OR and RR can be used to compare relative likelihood of desired outcomes 
between groups (Simon, 2001); they are different, particularly when the outcome event is 
frequent. However, the difference between the RR and OR is usually small for large studies 
and should not be a concern in terms of the accuracy of results. The issue is where the OR is 
misinterpreted as a RR. Unfortunately, this kind of misinterpretation of effect measure is often 
seen in primary studies as well as in systematic reviews and meta-analyses (Deeks et al., 2008). 
It is worth remembering that the OR is a good approximation of RR only under certain 
circumstances (Hosmer, Lemeshow, & Sturdivant, 2013). Other subtle differences between the 
two ratios are apparent when assessing heterogeneity between studies, Egger’s test and funnel 
plot asymmetry (Papageorgiou, Tsiranidou, Antonoglou, Deschner, & Jäger, 2015). 
An appropriate use of OR is in case-control studies where, usually, a dichotomous outcome 
variable is considered, and logistic regression is often adopted for the data analysis (Lee, Tan, 
& Chia, 2009). It is suggested to report the results of RCTs and systematic reviews in terms of 
RR by default (J. Deeks, 1998) and to avoid use of “risk of X” when the odds are the measure 
of an event (O'Connor, 2013). Finally, as the RR is easier to interpret and researchers often use 
it by default, it is preferable where it can be calculated (Simon, 2001).  
To avoid misinterpretation, researchers using cohort studies and randomized clinical trials 
should report RRs where possible, and other studies that use ORs should take care in 
interpreting this measure of effect (Knol et al., 2012). If the RR effect measure is used, it is 
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important to correctly interpret its magnitude, and the point estimate alone cannot be the basis 
for judging and interpreting the effectiveness of an intervention. The range of likely values for 
the RR should inform the interpretation of the effect, where statistical significance can be 
assumed if the 95% confidence interval (CI) around the RR does not include 1 (Scott, 2008). 
Where the intervention intends to prevent an undesirable outcome, an RR less than 1 indicates 
efficacy and in trials where the intervention aims to promote a positive event, a RR of more 
than 1 indicates intervention efficacy.  
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Table 1.  
a) Number of subjects assigned to interventions and outcome events (100 each in treatment and 
control groups) in the RCT example  
Intervention              Depression status 
Yes No Total 
Treatment group 
Psychological Support  
35 65 100 
Control group 
No Psychological Support 
70 30 100 
 
b) Number of subjects with and without current substance use disorder (200 patients and 420 
controls) in the case-control study example 
Substance Use Disorder status  Generalized Anxiety Disorder status 
 Yes No 
Yes  105 180 
No  95 240 
Total  200 420 
 
 
 
 
